ESMO Clinical Practice Guidelines: Haematological Malignancies
The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.
Latest enhanced and revised set of guidelines
ESMO has Clinical Practice Guidelines on the following Haematological Malignancies: Chronic myeloid leukaemia, Newly diagnosed and relapsed mantle cell lymphoma, Multiple myeloma, Newly diagnosed and relapsed follicular lymphoma, Extranodal diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma, Acute lymphoblastic leukaemia, Peripheral T-cell lymphomas, Diffuse large B cell lymphoma, Chronic lymphocytic leukaemia, Hairy cell leukaemia, Philadelphia chromosome-negative chronic myeloproliferative neoplasms, Myelodysplastic syndromes, Hodgkin's lymphoma, Primary cutaneous lymphoma, Acute myeloblastic leukaemia in adult patients, Waldenstrom's macroglobulinaemia, Gastric marginal zone lymphoma of MALT type.
They include information on incidence, diagnosis, staging and risk assessment, treatment, response evaluation and follow-up.
Haematologic malignancies
Acute Myeloblastic Leukaemia in Adult Patients: ESMO Clinical Practice Guidelines
Published in 2013 – Ann Oncol 2013; 24 (Suppl 6): vi138-vi143.
Authors: M.F. Fey, C. Buske
Haematologic malignancies
Waldenstrom’s Macroglobulinaemia: ESMO Clinical Practice Guidelines
Published in 2013 – Ann Oncol 2013; 24 (Suppl 6): vi125-vi132.
Authors: C. Buske, V. Leblond, M. Dimopoulos, E. Kimby, U. Jäger, M. Dreyling
Haematologic malignancies
Gastric Marginal Zone Lymphoma of MALT Type: ESMO Clinical Practice Guidelines
Published in 2013 – Ann Oncol 2013; 24 (Suppl 6): vi144-vi148.
Authors: E. Zucca, C. Copie-Bergman, U. Ricardi, C. Thieblemont, M. Raderer, M. Ladetto
Haematologic malignancies
ESMO Consensus Guidelines: Marginal Zone Lymphoma, Mantle Cell Lymphoma, Peripheral T-cell Lymphoma
Published in 2013 - Ann Oncol (2013) 24 (4): 857-877.
Authors: M. Dreyling, C. Thieblemont, A. Gallamini, L. Arcaini, E. Campo, O. Hermine, J. C. Kluin-Nelemans, M. Ladetto, S. Le Gouill, E. Iannitto, S. Pileri, J. Rodriguez, N. Schmitz, A. Wotherspoon, P. Zinzani, E. Zucca
Haematologic malignancies
ESMO Consensus Guidelines: Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma (FL) and Chronic Lymphocytic Leukemia (CLL)
Published in 2013 - Ann Oncol (2013) 24 (3): 561-576.
Authors: M. Ghielmini, U. Vitolo, E. Kimby, S. Montoto, J. Walewski, M. Pfreundschuh, M. Federico, P. Hoskin, C. McNamara, F. Caligaris-Cappio, S. Stilgenbauer, R. Marcus, M. Trneny, P. Dreger, E. Montserrat, M. Dreyling